Back to mobile site

Merck (MRK), Eisai Co. Granted FDA Breakthrough Therapy Designation for LENVIMA

July 31, 2018 5:46 AM EDT Send to a Friend
Eisai Co., Ltd. and Merck & Co., Inc. Kenilworth, N.J., U.S.A. (NYSE: MRK), known as MSD outside the United States ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login